Optimal Glycated Hemoglobin Cutoff for Diagnosis of Diabetes and Prediabetes in Chinese Breast Cancer Women
Xin-Yu Liang,Li-yuan Mu,Lei Hu,Rui-ling She,Chen-yu Ma,Jun-han Feng,Zhi-yu Jiang,Zhao-xing Li,Xiu-quan Qu,Bai-qing Peng,Kai-nan Wu,Ling-quan Kong
DOI: https://doi.org/10.2147/ijgm.s457158
IF: 2.145
2024-05-03
International Journal of General Medicine
Abstract:Xin-Yu Liang, 1, &ast Li-yuan Mu, 1, &ast Lei Hu, 2, &ast Rui-ling She, 1, &ast Chen-yu Ma, 1, &ast Jun-han Feng, 1, &ast Zhi-yu Jiang, 1 Zhao-xing Li, 1 Xiu-quan Qu, 1 Bai-qing Peng, 1 Kai-nan Wu, 1 Ling-quan Kong 1 1 Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China; 2 Information Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ling-quan Kong, Department of Breast and Thyroid Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China, Tel +8613101380893, Email Purpose: Glycated hemoglobin (HbA1c) is widely used in diabetes management and now recommended for diagnosis and risk assessment. Our research focused on investigating the optimal cutoff points of HbA1c for diagnosis of diabetes and prediabetes in Chinese breast cancer women, aiming to enhance early detection and tailor treatment strategies. Patients and Methods: This study involved 309 breast cancer women without diabetes history in China. Patients were categorized into groups of newly diagnosed diabetes, prediabetes, and normal glucose tolerance using oral glucose tolerance test (OGTT) according to the 2010 ADA criteria. HbA1c data were collected from all patients. Receiver operating characteristic (ROC) curve analysis was used to assess the effectiveness of the HbA1c screening. Results: Among the 309 breast cancer women without diabetes history, 96 (31.0%) were identified with diabetes and 130 (42.1%) had prediabetes according to OGTT, and the incidence of normal glucose tolerance was only 26.9% (83). ROC curve analysis, using OGTT as a reference, revealed that the area under the curve of 0.903 (P< 0.001, 95% CI, 0.867– 0.938) for HbA1c alone, indicating high accuracy. The optimal HbA1c cutoff for identifying diabetes was determined to be 6.0%, with a sensitivity of 78.1% and specificity of 86.4%. For prediabetes, the ROC curve for HbA1c alone showed that the area under the ROC curve of 0.703 (P< 0.001, 95% CI, 0.632– 0.774), with an optimal cutoff of 5.5% (sensitivity of 76.9% and specificity of 51.8%). Conclusion: The prevalence of undiagnosed diabetes is very high in breast cancer women without diabetes history in China. The optimal cutoff points of HbA1c for identifying diabetes and prediabetes are 6.0% and 5.5% in Chinese breast cancer women, respectively. Keywords: breast cancer, diabetes, HbA1c, prediabetes Globally, the prevalence of diabetes and breast cancer is rising significantly, especially in China. 1,2 Currently, female breast cancer has become the most diagnosed cancer worldwide, accounting for 11.7% of all new cancer diagnoses. 1 From 1980 to 2018, China experienced a significant shift in its health profile, with diabetes rates escalating sharply from just below 1% to 12.4%. 2 However, more than 61.9% of adults in China remain unaware of their diabetes condition. In the US, over 85% of individuals with prediabetes are also unaware of their condition. 2,3 Notably, as many as 50% of newly diagnosed type 2 diabetes patients had early indications of microvascular or macrovascular complications. A significant number of individuals with type 2 diabetes are frequently undiagnosed for several years, emphasizing the crucial role of early detection and timely intervention. 4 Prediabetes is an intermediate stage between normal glucose tolerance and diabetes. The International Diabetes Federation (IDF) emphasizes that prediabetes is a global concern. An epidemiological study in China showed that the prevalence of prediabetes was 38.1% in 2018. 2 Numerous studies have demonstrated that individuals with prediabetes are at a high risk of developing diabetes and experiencing higher rates of cardiovascular disease and mortality compared to the general population. With the increasing co-occurrence of diabetes and breast cancer becomes more common, there is a growing number of undiagnosed cases of diabetes and prediabetes are being observed among breast cancer patients. 5,6 This situation can substantially heighten both the financial burden and psychological distress, potentially resulting in higher mortality rates for these patients. 7–9 Consequently, the prompt and accurate diagnosis of diabetes and prediabetes in breast cancer patients is becoming crit -Abstract Truncated-
medicine, general & internal